What's new

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 9, Status: Authorised

Apr 7, 2025 - 15:19
 0
Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2025, European Me...

Next Article

4 Notable Health Tech Funding Announcements In March

Related Posts

Orphan designation: Treatment of X-linked hypohidrotic ectodermal dysplasia (Christ-Siemens-Touraine Syndrome), 26/02/2025 Positive

Orphan designation: Treatment of X-linked hypohidrotic...

Mar 11, 2025  0

EMEA-003512-PIP01-23

EMEA-003512-PIP01-23

Mar 26, 2025  0

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0